Home  >  News
Eppen_Freedom_Oct2022
 Premier Research India
you can get e-magazine links on WhatsApp. Click here
News
  SQZ Biotech publishes preclinical research demonstrating SQZ AAC platform’s potential as an effective red blood cell-derived immunotherapy,   October 04, 2022
  US FDA clears Kira Pharma’s IND application to begin phase 2 trial of KP104 in SLE-TMA,   October 04, 2022
  US FDA clears Immuneering’s IND application for phase 1/2a trial of IMM-1-104 to treat advanced solid tumours with RAS mutations,   October 03, 2022
  Regeneron presents positive results from aflibercept 8 mg in patients with diabetic macular edema & wAMD at AAO meeting,   October 03, 2022
  Zealand Pharma reports positive results from phase 3 trial of glepaglutide in patients with short bowel syndrome,   October 03, 2022
  Kinarus discontinues phase 2 KINETIC study of KIN001 in hospitalized Covid-19 patients following a prespecified interim analysis of efficacy and safety,   October 03, 2022
  Oxilio, Quotient Sciences receive UK MHRA nod to begin clinical trial with OXL001,   October 01, 2022
  Study shows bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods,   October 01, 2022
  CIRM awards $6.85 million grant to Excision Bio to support ongoing phase 1/2 trial of EBT-101 as potential cure for HIV,   September 30, 2022
  Kling Bio begins patient dosing in phase 1b trial of KBA1412 in patients with advanced solid tumours,   September 30, 2022
  Acticor Biotech begins patient enrollment in phase 2/3 ACTISAVE study of glenzocimab to treat acute ischemic stroke,   September 28, 2022
  Angel Pharma gets Chinese approval to initiate phase 1/1b trial of mupadolimab,   September 28, 2022
  Nykode announces positive results from phase 1/2 open label, dose escalation trial of its T cell focused SARS-CoV-2 vaccine candidate,   September 28, 2022
  US FDA clears CatalYm’s IND application to expand phase 2 clinical programme of visugromab in advanced cancer patients,   September 28, 2022
  TILT Biotherapeutics collaborates with MSD on immunotherapy trial in checkpoint inhibitor refractory NSCLC,   September 27, 2022
  Brii Biosciences announces positive results from phase 1 study of BRII-296 to treat postpartum depression,   September 27, 2022
  China NMPA approves Everest Medicines IND application for phase 1b study of EVER001, a novel BTK inhibitor to treat renal diseases,   September 27, 2022
  Citius Pharma collaborates with University of Pittsburgh for phase 1 investigator-initiated study to evaluate I/ONTAK in combo with pembrolizumab in solid tumours,   September 26, 2022
  New US FDA draft guidance aims to protect children who participate in clinical trials,   September 26, 2022
  Ionis Pharma announces topline results from phase 2b SOLANO study in patients with hypercholesterolemia,   September 24, 2022

 Back
 
truking"
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |